Drug & Supplement Interaction Checker
Check potential pharmacological interactions between research peptides and prescription medications, dietary supplements, or other peptides. Select your compound and current medications to view severity-rated interaction profiles.
Select a peptide, then choose your medications and supplements to check for known or theoretical interactions.
Research Disclaimer: This tool provides educational reference data based on published pharmacological research and theoretical mechanism analysis. Interaction data may be incomplete or theoretical. This is not medical advice. Always consult a qualified healthcare provider before combining any compounds. Absence of a listed interaction does not guarantee safety.
1
Select a Peptide
2
Select Current Medications & Supplements
Interaction Results
All
Severe
Moderate
Mild
None
Frequently Asked Questions
Can peptides interact with prescription medications?
Yes, peptides can interact with prescription medications through several mechanisms. GLP-1 agonists like Semaglutide and Tirzepatide can potentiate the effects of insulin and sulfonylureas, increasing hypoglycemia risk. Growth hormone secretagogues such as MK-677 and Ipamorelin may affect blood glucose regulation and interact with diabetes medications. BPC-157 has gastric acid-modulating properties that could theoretically alter absorption of orally administered drugs. Always consult a healthcare provider before combining peptides with prescription medications.
Is it safe to take supplements while using peptides?
Most common supplements have minimal interaction risk with peptides. However, some combinations warrant caution: NAC may modulate nitric oxide pathways that overlap with BPC-157 mechanisms, curcumin has anticoagulant properties that could compound with peptides affecting platelet function, and high-dose zinc can influence copper metabolism relevant to GHK-Cu efficacy. Fish oil at high doses combined with BPC-157 may increase bleeding tendency due to additive effects on platelet aggregation.
Can I stack multiple peptides together safely?
Many peptide combinations are commonly used in research protocols, but some stacks require careful consideration. Combining multiple GH secretagogues (e.g., Ipamorelin + CJC-1295 + MK-677) may cause excessive IGF-1 elevation and insulin resistance. Stacking GLP-1 agonists (Semaglutide + Tirzepatide) is generally not recommended due to compounding gastrointestinal side effects and hypoglycemia risk. Recovery peptides like BPC-157 + TB-500 are commonly stacked with a well-established safety profile in research settings.
Do blood thinners interact with peptides?
Several peptides warrant caution when used alongside anticoagulants like warfarin, heparin, or DOACs. BPC-157 has been shown in animal studies to influence platelet aggregation and could theoretically potentiate or antagonize anticoagulant effects. TB-500 promotes angiogenesis and tissue remodeling, which may be relevant in patients on blood thinners. GHK-Cu has wound-healing properties that interact with the coagulation cascade. Monitoring INR and bleeding signs is advisable.
How does this interaction checker work?
This tool cross-references a curated database of known and theoretical pharmacological interactions between peptides and common medications, supplements, and other peptides. Interactions are classified by severity (None, Mild, Moderate, Severe) based on published research, pharmacological mechanism analysis, and clinical reports. The database is regularly updated as new research emerges. This tool is for educational reference only and does not replace professional medical guidance.
Related Tools & Resources
